FDAnews

CLINICAL DATA INITIATES PATIENT ENROLLMENT FOR VILAZODONE TRIAL

Clinical Data has initiated patient enrollment in a pivotal Phase III clinical research study of vilazodone, a novel dual serotonergic antidepressant compound being studied for treatment of depression.

The company anticipates having initial results from this study available by mid-2007 and anticipates at least one long-term safety study and one additional pivotal study will be required prior to filing a new drug application.